Catherine Tighe

Catherine Tighe is an accomplished scientist specializing in medicinal chemistry, currently serving as Lead Scientist at Nxera Pharma since April 2021. Prior to this role, Catherine held various positions at The Institute of Cancer Research, including Postdoctoral Training Fellow focused on a Hit-to-Lead project under Dr. Gurdip Bhalay. Catherine also contributed to oncology research as a Research Fellow at the University of Sussex, developing kinase inhibitors in collaboration with AstraZeneca. Earlier experience includes roles as a Laboratory Demonstrator at University College Dublin and a Research Fellow at Gadea Grupo Farmacéutico, along with a summer internship at Amgen in Quality Assurance. Catherine earned a PhD in Organic Chemistry and a B.Sc. in Medicinal Chemistry and Chemical Biology from University College Dublin.